![](/img/cover-not-exists.png)
Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? Yes
J. E. Exaire, A. M. LincoffVolume:
2
Year:
2004
Language:
english
Pages:
3
DOI:
10.1111/j.1538-7836.2004.00559.x
File:
PDF, 52 KB
english, 2004